Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets.
Saved in:
| Title: | Type 2 diabetes candidate genes, including PAX5, cause impaired insulin secretion in human pancreatic islets. |
|---|---|
| Authors: | Bacos K; Epigenetics and Diabetes Unit, Department of Clinical Sciences and., Perfilyev A; Epigenetics and Diabetes Unit, Department of Clinical Sciences and., Karagiannopoulos A; Unit of Islet Cell Exocytosis, Department of Clinical Sciences, Lund University Diabetes Centre, Scania University Hospital, Malmö, Scania, Sweden., Cowan E; Unit of Islet Cell Exocytosis, Department of Clinical Sciences, Lund University Diabetes Centre, Scania University Hospital, Malmö, Scania, Sweden., Ofori JK; Epigenetics and Diabetes Unit, Department of Clinical Sciences and., Bertonnier-Brouty L; Endocrine Cell Differentiation, Department of Laboratory Medicine, Lund Stem Cell Center, Malmö, Scania, Sweden., Rönn T; Epigenetics and Diabetes Unit, Department of Clinical Sciences and., Lindqvist A; Neuroendocrine Cell Biology, Department of Experimental Medical Science., Luan C; Unit of Islet Pathophysiology, Department of Clinical Sciences., Ruhrmann S; Epigenetics and Diabetes Unit, Department of Clinical Sciences and., Ngara M; Neuroendocrine Cell Biology, Department of Experimental Medical Science., Nilsson Å; Human Tissue Lab, Department of Clinical Sciences., Gheibi S; Molecular Metabolism Unit, Department of Clinical Sciences, and., Lyons CL; Molecular Metabolism Unit, Department of Clinical Sciences, and., Lagerstedt JO; Unit of Islet Cell Exocytosis, Department of Clinical Sciences, Lund University Diabetes Centre, Scania University Hospital, Malmö, Scania, Sweden., Barghouth M; Unit of Islet Pathophysiology, Department of Clinical Sciences., Esguerra JL; Unit of Islet Cell Exocytosis, Department of Clinical Sciences, Lund University Diabetes Centre, Scania University Hospital, Malmö, Scania, Sweden., Volkov P; Epigenetics and Diabetes Unit, Department of Clinical Sciences and., Fex M; Molecular Metabolism Unit, Department of Clinical Sciences, and., Mulder H; Molecular Metabolism Unit, Department of Clinical Sciences, and., Wierup N; Neuroendocrine Cell Biology, Department of Experimental Medical Science., Krus U; Human Tissue Lab, Department of Clinical Sciences., Artner I; Endocrine Cell Differentiation, Department of Laboratory Medicine, Lund Stem Cell Center, Malmö, Scania, Sweden., Eliasson L; Unit of Islet Cell Exocytosis, Department of Clinical Sciences, Lund University Diabetes Centre, Scania University Hospital, Malmö, Scania, Sweden., Prasad RB; Genomics, Diabetes and Endocrinology, Department of Clinical Sciences, Lund University Diabetes Centre, Scania University Hospital, Malmö, Scania, Sweden.; Institute of Molecular Medicine (FIMM), Helsinki University, Helsinki, Finland., Cataldo LR; Molecular Metabolism Unit, Department of Clinical Sciences, and.; The Novo Nordisk Foundation Centre for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Ling C; Epigenetics and Diabetes Unit, Department of Clinical Sciences and. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2023 Feb 15; Vol. 133 (4). Date of Electronic Publication: 2023 Feb 15. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
